Zobrazeno 1 - 6
of 6
pro vyhledávání: '"mao-lin Ai"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundVoriconazole (VRZ) is involved in a variety of drug‒drug interactions (DDIs), but few studies have reported adverse events (AEs) associated with the DDIs of VRZ. The primary goal of this study was to analyse the potential risk factors for
Externí odkaz:
https://doaj.org/article/56fe1329d2584377aeb1499955f02e4a
Autor:
Ling Shu, Ben‐nian Huo, Nan‐ge Yin, Hong‐jun Xie, Aga Erbu, Mao‐lin Ai, Yun‐tao Jia, Lin Song
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract Detailed data on safety associated with drug–drug interactions (DDIs) between Linezolid (LZD) and other antibiotics are limited. The aim of this study was to investigate the safety signals related to these DDIs and to provide a reference f
Externí odkaz:
https://doaj.org/article/07461b31704144769705f8246abe4bf3
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Although discontinuation is common in clinical trials, no study has been conducted to analyse the current situation and reasons for the suspension or discontinuation of drug clinical trials in China. This study aims to analyse the
Externí odkaz:
https://doaj.org/article/0e459245411d41149f1fd7261a0c486d
Publikováno v:
BMC Medical Research Methodology
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-10 (2021)
Background Although discontinuation is common in clinical trials, no study has been conducted to analyse the current situation and reasons for the suspension or discontinuation of drug clinical trials in China. This study aims to analyse the general
Background: Although discontinuation is common in clinical trials, no study has been conducted to analyse the current situation and reasons for the suspension or discontinuation of drug clinical trials in China. This study aims to analyse the general
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbb8493f483aa092d5cebc11a84d24ac
https://doi.org/10.21203/rs.3.rs-131119/v1
https://doi.org/10.21203/rs.3.rs-131119/v1
Objective: Randomized controlled trials (RCTs) are usually the basis of evidence-based medicine and provide important information for pediatric clinical practice, but whether the results of RCTs can be correctly translated into clinical practice depe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b81daf6e62271c61492b78994076ddc
https://doi.org/10.21203/rs.3.rs-42302/v1
https://doi.org/10.21203/rs.3.rs-42302/v1